Product Pipeline
Enabling Consortia-Based Therapeutics Through CORAL®
MRM Health’s pipeline includes programs in inflammatory bowel diseases, other inflammatory disorders and immune-oncology, as well as an incubator program in liver diseases and an animal health program as part of a corporate partnership.
Manufacturing Breakthrough
MRM Health leverages its proprietary CORAL® platform to design, optimize, and manufacture live bacterial consortia with targeted therapeutic potential.
Read More
Proprietary Platform
Our consortia are precision-engineered and optimized to restore microbiome function and improve disease outcomes, with excellent safety profile and disease-modifying potential.
Single Drug Substance
Our unique manufacturing process enables production of multi-strain consortia as a single Drug Substance, ensuring scalability and cost-efficiency.
Effective live biotherapeutics
Designed for efficacy, developed for synergy, produced as one.
Contact us